Asma Beldi‐Ferchiou

1.7k total citations
21 papers, 813 citations indexed

About

Asma Beldi‐Ferchiou is a scholar working on Oncology, Immunology and Pathology and Forensic Medicine. According to data from OpenAlex, Asma Beldi‐Ferchiou has authored 21 papers receiving a total of 813 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 9 papers in Immunology and 7 papers in Pathology and Forensic Medicine. Recurrent topics in Asma Beldi‐Ferchiou's work include Immune Cell Function and Interaction (7 papers), CAR-T cell therapy research (5 papers) and Lymphoma Diagnosis and Treatment (5 papers). Asma Beldi‐Ferchiou is often cited by papers focused on Immune Cell Function and Interaction (7 papers), CAR-T cell therapy research (5 papers) and Lymphoma Diagnosis and Treatment (5 papers). Asma Beldi‐Ferchiou collaborates with scholars based in France, United Kingdom and Tunisia. Asma Beldi‐Ferchiou's co-authors include Sophie Caillat‐Zucman, Marie‐Hélène Delfau‐Larue, Stéphanie Dogniaux, D. Zucman, Stéphanie Dupuy, D. Sène, Éric Vivier, Célèste Lebbé, Fréderic Vély and Daniel Olive and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Asma Beldi‐Ferchiou

21 papers receiving 806 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Asma Beldi‐Ferchiou France 13 420 348 145 144 127 21 813
Judith Diment Israel 13 184 0.4× 113 0.3× 84 0.6× 91 0.6× 78 0.6× 28 578
Edoardo Migliori Belgium 13 590 1.4× 593 1.7× 43 0.3× 184 1.3× 57 0.4× 22 942
Shizuyo Tsujimura Japan 16 286 0.7× 234 0.7× 89 0.6× 101 0.7× 45 0.4× 33 969
K. H. Fu China 15 191 0.5× 455 1.3× 363 2.5× 253 1.8× 34 0.3× 26 906
L J Elwood United States 10 251 0.6× 267 0.8× 122 0.8× 183 1.3× 38 0.3× 12 756
Luis Caminal‐Montero Spain 15 353 0.8× 70 0.2× 103 0.7× 122 0.8× 37 0.3× 68 762
Hassan El‐Solh Saudi Arabia 15 86 0.2× 226 0.6× 164 1.1× 261 1.8× 24 0.2× 40 693
Sotirios P. Fortis Greece 14 294 0.7× 331 1.0× 27 0.2× 245 1.7× 43 0.3× 56 746
Naohiko Aozasa Japan 19 222 0.5× 270 0.8× 511 3.5× 255 1.8× 43 0.3× 44 973

Countries citing papers authored by Asma Beldi‐Ferchiou

Since Specialization
Citations

This map shows the geographic impact of Asma Beldi‐Ferchiou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Asma Beldi‐Ferchiou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Asma Beldi‐Ferchiou more than expected).

Fields of papers citing papers by Asma Beldi‐Ferchiou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Asma Beldi‐Ferchiou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Asma Beldi‐Ferchiou. The network helps show where Asma Beldi‐Ferchiou may publish in the future.

Co-authorship network of co-authors of Asma Beldi‐Ferchiou

This figure shows the co-authorship network connecting the top 25 collaborators of Asma Beldi‐Ferchiou. A scholar is included among the top collaborators of Asma Beldi‐Ferchiou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Asma Beldi‐Ferchiou. Asma Beldi‐Ferchiou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Beldi‐Ferchiou, Asma, Vincent Audard, François Lemonnier, et al.. (2022). Evaluation of a new ELISA assay for monoclonal free‐light chain detection in patients with cardiac amyloidosis. SHILAP Revista de lepidopterología. 3(3). 828–837. 3 indexed citations
2.
Plonquet, Anne, et al.. (2022). Optimized Flow Cytometry Strategy for Phenotyping Intramuscular Leukocytes: Application to the Evaluation of Myopathological Processes. Journal of Neuropathology & Experimental Neurology. 81(3). 193–207. 2 indexed citations
3.
Moatti, Audrey, Caroline Pilon, Asma Beldi‐Ferchiou, et al.. (2022). TNFR2 blockade of regulatory T cells unleashes an antitumor immune response after hematopoietic stem-cell transplantation. Journal for ImmunoTherapy of Cancer. 10(4). e003508–e003508. 15 indexed citations
4.
Bendib, Inès, Asma Beldi‐Ferchiou, F. Schlemmer, et al.. (2021). Functional Ex Vivo Testing of Alveolar Monocytes in Patients with Pneumonia-Related ARDS. Cells. 10(12). 3546–3546. 5 indexed citations
5.
Bendib, Inès, Asma Beldi‐Ferchiou, F. Schlemmer, et al.. (2021). Alveolar compartmentalization of inflammatory and immune cell biomarkers in pneumonia-related ARDS. Critical Care. 25(1). 23–23. 26 indexed citations
6.
Belhadj, Karim, Jehan Dupuis, Louise Roulin, et al.. (2021). Venetoclax induces profound and sustained responses in patients with relapsed/refractory light‐chain amyloidosis. British Journal of Haematology. 193(3). 674–677. 13 indexed citations
7.
Hüe, Sophie, Asma Beldi‐Ferchiou, Inès Bendib, et al.. (2020). Uncontrolled Innate and Impaired Adaptive Immune Responses in Patients with COVID-19 Acute Respiratory Distress Syndrome. American Journal of Respiratory and Critical Care Medicine. 202(11). 1509–1519. 133 indexed citations
8.
Beldi‐Ferchiou, Asma, Abir Wahab, Matthieu Duchmann, et al.. (2020). High effector-memory CD8+ T-cell levels correlate with high PML risk in natalizumab-treated patients. Multiple Sclerosis and Related Disorders. 46. 102470–102470. 3 indexed citations
9.
Oniszczuk, Julie, Asma Beldi‐Ferchiou, Étienne Audureau, et al.. (2020). Circulating plasmablasts and high level of BAFF are hallmarks of minimal change nephrotic syndrome in adults. Nephrology Dialysis Transplantation. 36(4). 609–617. 23 indexed citations
10.
Bras, Fabien Le, Jehan Dupuis, Silvia Oghina, et al.. (2020). Daratumumab is safe and induces a rapid hematological response in light-chain amyloidosis with severe cardiac impairment. Leukemia & lymphoma. 62(4). 979–983. 7 indexed citations
11.
Bendib, Inès, Luc de Chaisemartin, Vanessa Granger, et al.. (2019). Neutrophil Extracellular Traps Are Elevated in Patients with Pneumonia-related Acute Respiratory Distress Syndrome. Anesthesiology. 130(4). 581–591. 67 indexed citations
12.
Pilon, Caroline, Thomas Stehlé, Asma Beldi‐Ferchiou, et al.. (2019). Human Apoptotic Cells, Generated by Extracorporeal Photopheresis, Modulate Allogeneic Immune Response. Frontiers in Immunology. 10. 2908–2908. 12 indexed citations
13.
14.
Chiu, Hsiling, Preeti Trisal, Chad C. Bjorklund, et al.. (2019). Combination lenalidomide‐rituximab immunotherapy activates anti‐tumour immunity and induces tumour cell death by complementary mechanisms of action in follicular lymphoma. British Journal of Haematology. 185(2). 240–253. 37 indexed citations
15.
16.
Khanfir, M., Asma Beldi‐Ferchiou, Soumaya Marzouki, et al.. (2018). Impaired TGF-β signaling in patients with active systemic lupus erythematosus is associated with an overexpression of IL-22. Cytokine. 108. 182–189. 21 indexed citations
17.
Beldi‐Ferchiou, Asma, et al.. (2017). Place de l’immunophénotypage sanguin et de l’étude de la clonalité dans la prise en charge des lymphomes T cutanés. Annales de Dermatologie et de Vénéréologie. 144(4). 315–322. 1 indexed citations
18.
Beldi‐Ferchiou, Asma, Abderrahman Abdelkefi, Saloua Ladeb, et al.. (2017). Abnormal repression of SHP-1, SHP-2 and SOCS-1 transcription sustains the activation of the JAK/STAT3 pathway and the progression of the disease in multiple myeloma. PLoS ONE. 12(4). e0174835–e0174835. 38 indexed citations
19.
Beldi‐Ferchiou, Asma & Sophie Caillat‐Zucman. (2017). Control of NK Cell Activation by Immune Checkpoint Molecules. International Journal of Molecular Sciences. 18(10). 2129–2129. 63 indexed citations
20.
Beldi‐Ferchiou, Asma, Marion Lambert, Stéphanie Dogniaux, et al.. (2016). PD-1 mediates functional exhaustion of activated NK cells in patients with Kaposi sarcoma. Oncotarget. 7(45). 72961–72977. 243 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Judith Diment Breakdown of academic impact, for papers by Edoardo Migliori Breakdown of academic impact, for papers by Shizuyo Tsujimura Breakdown of academic impact, for papers by K. H. Fu Breakdown of academic impact, for papers by L J Elwood Breakdown of academic impact, for papers by Luis Caminal‐Montero Breakdown of academic impact, for papers by Hassan El‐Solh Breakdown of academic impact, for papers by Sotirios P. Fortis Breakdown of academic impact, for papers by Naohiko Aozasa
Rankless by CCL
2026